RDY
Dr. Reddy'S Laboratories·NYSE
--
--(--)
--
--(--)
Dr. Reddy'S Laboratories (RDY) Company Profile
Dr. Reddy'S Laboratories Limited
An Indian developer of active pharmaceutical ingredients, intermediates, and finished dosage forms
Chemical and pharmaceutical
02/24/1984
04/11/2001
New York Stock Exchange
27,527
03-31
Depository Receipts (Ordinary Shares)
8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500034, India
Sells pharmaceutical products and provides development and manufacturing services.
Dr. Reddy'S Laboratories Limited was established on February 24, 1984. The company is a global integrated pharmaceutical company dedicated to accelerating the availability of affordable and innovative medicines. The Company's business is divided into three reporting segments: Global Generics (production and sales of prescription and over-the-counter pharmaceutical products), pharmaceutical services and active ingredients (production and sales of active pharmaceutical ingredients and intermediates, and provision of contract research services), and other businesses (including a discovery-stage biotechnology company focused on developing oncology and inflammation therapies, and a proprietary products business focused on differentiated formulations). The company's main markets include the United States, India, Russia and other former Soviet Union countries as well as Europe.
